Investigating the role of EZH2 as a therapeutic target in clear cell renal cell carcinoma (ccRCC)

被引：0
|
作者：
Wei, Darmood
Ricketts, Christopher J.
Schmidt, Laura S.
Yang, Youfeng
Vocke, Cathy D.
Linehan, William M.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-4707
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4707
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Expression of EZH2 in renal cell carcinoma as a novel prognostic marker
    Lee, Hye Won
    Choe, Misun
    PATHOLOGY INTERNATIONAL, 2012, 62 (11) : 735 - 741
  • [32] Identification of Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma (ccRCC) by Transcriptomics
    Zhang, Sihong
    Xu, Xianglai
    Wang, Yelin
    Zhu, Yanjun
    Wang, Jiajun
    Wang, Hang
    Guo, Jianming
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2021, 51 (05): : 597 - 608
  • [33] RCC1 functions as a tumor facilitator in clear cell renal cell carcinoma by dysregulating cell cycle, apoptosis, and EZH2 stability
    Wu, Yunfei
    Xu, Zhijie
    Chen, Xiaoyi
    Fu, Guanghou
    Tian, Junjie
    Jin, Baiye
    CANCER MEDICINE, 2023, 12 (19): : 19889 - 19903
  • [34] Epigenetic reactivation of PEG3 by EZH2 inhibitors suppresses renal clear cell carcinoma progress
    Qiu, Teng
    Ding, Yuanyuan
    Qin, Jingting
    Ren, Dexu
    Xie, Mengru
    Qian, Qilan
    Wang, Yasong
    Ma, Ling
    Jing, Aixin
    Yang, Jiayan
    Ma, Shaojie
    Wang, Xiujun
    Wang, Weiling
    Ji, Jing
    Li, Guanchu
    CELLULAR SIGNALLING, 2023, 107
  • [35] Differencial proteome of clear-cell renal cell carcinoma (ccRCC) tissues
    Vieira de Ribeiro, Ana Julia
    Sandim, Vanessa
    Ornellas, Antonio Augusto
    Reis, Rodrigo Siqueira
    Domont, Gilberto
    Alves, Gilda
    INTERNATIONAL BRAZ J UROL, 2013, 39 (01): : 83 - 94
  • [36] Expression of miRNA-21 and miRNA-221 in clear cell renal cell carcinoma (ccRCC) and their possible role in the development of ccRCC
    Szabo, Zsuzsanna
    Szegedi, Krisztian
    Gombos, Katalin
    Mahua, Choudhury
    Flasko, Tibor
    Harda, Kristof
    Halmos, Gabor
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (12) : 533.e21 - 533.e27
  • [37] Therapeutic target for HIF-2α antagonist-resistant clear cell renal cell carcinoma
    Son, D. H.
    Hong, S. H.
    Hwang, H. J.
    Kim, E. S.
    Park, S. Y.
    Yoon, Y. E.
    EUROPEAN UROLOGY, 2023, 83
  • [38] TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma
    Glaser, Zachary A.
    Love, Harold D.
    Guo, Shunhua
    Gellert, Lan
    Chang, Sam S.
    Herrell, Stanley Duke
    Barocas, Daniel A.
    Penson, David F.
    Cookson, Michael S.
    Clark, Peter E.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (05) : 286 - 293
  • [39] EZH2 as a therapeutic target for glioma
    Faruck, Lukmanul Hakkim
    Day, Charles
    Bhattarai, Suraj
    Langfald, Alyssa
    Hinchcliffe, Edward
    Robinson, James
    CANCER RESEARCH, 2024, 84 (05)
  • [40] Metabolic classification of clear cell renal cell carcinoma and search for therapeutic target metabolites
    Naito, Sei
    Ito, Hiromi
    Makinoshima, Hideki
    Tsuchiya, Norihiko
    CANCER SCIENCE, 2023, 114 : 2167 - 2167
12345